UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 215

Sortiert nach

Is the HPA Axis as Target for Depression Outdated, or Is There a New Hope?

Frontiers in psychiatry, 2019-02, Vol.10, p.101-101

Menke, Andreas

2019

Volltextzugriff (PDF)

Neuromodulator and Emotion Biomarker for Stress Induced Mental Disorders

Neural plasticity, 2016-01, Vol.2016, p.2609128-6

2016

Volltextzugriff (PDF)

A Case-Control Study and Meta-Analysis Reveal BDNF Val66Met Is a Possible Risk Factor for PTSD

Neural plasticity, 2016-01, Vol.2016, p.6979435-10

2016

Volltextzugriff (PDF)

Epigenetic alterations in depression and antidepressant treatment

Dialogues in clinical neuroscience, 2014-09, Vol.16 (3), p.395-404

2014

Volltextzugriff (PDF)

FKBP5 methylation predicts treatment response in major depressive disorder

Psychoneuroendocrinology, 2024-02, Vol.160, p.106705, Article 106705

Menke, Andreas

2024

Volltextzugriff (PDF)

MicroRNA 135 Is Essential for Chronic Stress Resiliency, Antidepressant Efficacy, and Intact Serotonergic Activity

Neuron (Cambridge, Mass.), 2014-07, Vol.83 (2), p.344-360

2014

Volltextzugriff (PDF)

The HPA Axis as Target for Depression

Current neuropharmacology, 2024-01, Vol.22 (5), p.904-915

Menke, Andreas

2024

Volltextzugriff (PDF)

Dexamethasone Stimulated Gene Expression in Peripheral Blood is a Sensitive Marker for Glucocorticoid Receptor Resistance in Depressed Patients

Neuropsychopharmacology (New York, N.Y.), 2012-05, Vol.37 (6), p.1455-1464

2012

Volltextzugriff (PDF)

Sex-related differential response to dexamethasone in endocrine and immune measures in depressed in-patients and healthy controls

Journal of psychiatric research, 2018-03, Vol.98, p.107-115

2018

Volltextzugriff (PDF)

When a test is more than just a test: Findings from patient interviews and survey in the trial of a technology to measure antidepressant medication response (the PReDicT Trial)

Comprehensive psychiatry, 2024-07, Vol.132, p.152467, Article 152467

2024

Volltextzugriff (PDF)

The HPA Axis as Target for Depression

Current neuropharmacology, 2023, Vol.22 (5), p.904-915

Andreas Menke

2023

Volltextzugriff (PDF)

Effects of Anxious Depression on Antidepressant Treatment Response

International journal of molecular sciences, 2023-12, Vol.24 (24), p.17128

2023

Volltextzugriff (PDF)

How to measure glucocorticoid receptor’s sensitivity in patients with stress-related psychiatric disorders

Psychoneuroendocrinology, 2018-05, Vol.91, p.235-260

2018

Volltextzugriff (PDF)

Epigenetics, depression and antidepressant treatment

Current pharmaceutical design, 2012-12, Vol.18 (36), p.5879

2012

Volltextzugriff (PDF)

Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment

Neuropsychopharmacology (New York, N.Y.), 2010-02, Vol.35 (3), p.727-740

2010

Volltextzugriff (PDF)

Identification of dynamic glucocorticoid-induced methylation changes at the FKBP5 locus

Clinical epigenetics, 2019-05, Vol.11 (1), p.83-14, Article 83

2019

Volltextzugriff (PDF)

Can the DEX/CRH test or markers of oxidative stress distinguish work-related stress from major depressive disorder and normal controls?

Stress (Amsterdam, Netherlands), 2024-12, Vol.27 (1), p.2353781

2024

Volltextzugriff (PDF)

Clinical characteristics and treatment outcome in a representative sample of depressed inpatients – Findings from the Munich Antidepressant Response Signature (MARS) project

Journal of psychiatric research, 2009-01, Vol.43 (3), p.215-229

2009

Volltextzugriff (PDF)

The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial

Trials, 2017-11, Vol.18 (1), p.558-10, Article 558

2017

Volltextzugriff (PDF)

Blood-based biomarkers predicting response to antidepressants

Journal of Neural Transmission, 2019-01, Vol.126 (1), p.47-63

2019

Volltextzugriff (PDF)

Long-term effects of stress early in life on microRNA-30a and its network: Preventive effects of lurasidone and potential implications for depression vulnerability

Neurobiology of stress, 2020-11, Vol.13, p.100271-100271, Article 100271

2020

Volltextzugriff (PDF)

Impact of Novel Antidepressants on Cardiac 123I-Metaiodobenzylguanidine Uptake: Experimental Studies on SK-N-SH Cells and Healthy Rabbits

The Journal of nuclear medicine (1978), 2018-07, Vol.59 (7), p.1099-1103

2018

Volltextzugriff (PDF)

Glucocorticoid receptor challenge tests in major depression

Psychoneuroendocrinology, 2016-09, Vol.71, p.71-71

Menke, Andreas

2016

Volltextzugriff (PDF)

Precision pharmacotherapy: psychiatry's future direction in preventing, diagnosing, and treating mental disorders

Pharmacogenomics and personalized medicine, 2018-01, Vol.11, p.211-222

Menke, Andreas

2018

Volltextzugriff (PDF)

1 – 25 von 215

Suche als RSS-Feed

Aktive Filter

SpracheDeutsch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(198)

Publikationsform

Sprache

Englisch
(215)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Is the HPA Axis as Target for Depression Outdated, or Is There a New Hope?

Neuromodulator and Emotion Biomarker for Stress Induced Mental Disorders

A Case-Control Study and Meta-Analysis Reveal BDNF Val66Met Is a Possible Risk Factor for PTSD

Epigenetic alterations in depression and antidepressant treatment

FKBP5 methylation predicts treatment response in major depressive disorder

MicroRNA 135 Is Essential for Chronic Stress Resiliency, Antidepressant Efficacy, and Intact Serotonergic Activity

The HPA Axis as Target for Depression

Dexamethasone Stimulated Gene Expression in Peripheral Blood is a Sensitive Marker for Glucocorticoid Receptor Resistance in Depressed Patients

Sex-related differential response to dexamethasone in endocrine and immune measures in depressed in-patients and healthy controls

When a test is more than just a test: Findings from patient interviews and survey in the trial of a technology to measure antidepressant medication response (the PReDicT Trial)

The HPA Axis as Target for Depression

The Neuronal Transporter Gene SLC6A15 Confers Risk to Major Depression

Effects of Anxious Depression on Antidepressant Treatment Response

How to measure glucocorticoid receptor’s sensitivity in patients with stress-related psychiatric disorders

Epigenetics, depression and antidepressant treatment

Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment

Identification of dynamic glucocorticoid-induced methylation changes at the FKBP5 locus

Can the DEX/CRH test or markers of oxidative stress distinguish work-related stress from major depressive disorder and normal controls?

Clinical characteristics and treatment outcome in a representative sample of depressed inpatients – Findings from the Munich Antidepressant Response Signature (MARS) project

The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial

Blood-based biomarkers predicting response to antidepressants

Long-term effects of stress early in life on microRNA-30a and its network: Preventive effects of lurasidone and potential implications for depression vulnerability

Impact of Novel Antidepressants on Cardiac 123I-Metaiodobenzylguanidine Uptake: Experimental Studies on SK-N-SH Cells and Healthy Rabbits

Glucocorticoid receptor challenge tests in major depression

Precision pharmacotherapy: psychiatry's future direction in preventing, diagnosing, and treating mental disorders

Aktive Filter

Suchergebnisse filtern